Alexandra Balcom, Chief Financial Officer at Nuvalent, Inc. (NUVL), sold 50,000 shares at $48.61 ($2.4M) on 2023-07-31, disclosed to the SEC on 2023-08-01.
Scheduled sale ($2.4M) by Chief Financial Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $48.61 | 14,152 | $688K | 28.1% |
| 2 | $48.61 | 14,152 | $688K | 28.1% |
| 3 | $49.49 | 10,848 | $537K | 21.9% |
| 4 | $49.49 | 10,848 | $537K | 21.9% |
| Total | $48.99 avg | 50,000 | $2.4M | 100% |
| Filing → |
| NUVL | SELL | 2026-05-05 | $1.1M | — | Filing → |
| NUVL | SELL | 2026-04-03 | $1.2M | — | Filing → |
| NUVL | SELL | 2026-03-26 | $2.5M | — | Filing → |